Survival and Quality of Life Following Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colonic Origin

@article{AdrienneRHill2011SurvivalAQ,
  title={Survival and Quality of Life Following Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colonic Origin},
  author={DO AdrienneR.Hill and Richard P. McQuellon and MS GregoryB.Russell and Perry Shen and IV JohnH.Stewart and E. A. Levine},
  journal={Annals of Surgical Oncology},
  year={2011},
  volume={18},
  pages={3673-3679}
}
Peritoneal carcinomatosis of colonic origin (PCC) is a life-threatening diagnosis. Cytoreductive surgery (CS) with hyperthermic intraperitoneal chemotherapy (HIPEC) offers patients the prospect of long-term survival with alleviation of symptoms. Patients underwent HIPEC for PCC and completed questionnaires preoperatively (T1) and after surgery at 3 (T2), 6 (T3), and 12 (T4) months. Questionnaires included the Functional Assessment of Cancer Therapy—Colon (FACT-C), Brief Pain Inventory (BPI), SF… CONTINUE READING